ArticleScientific reports2026
In vitro evaluation of a decellularized human fetal skin-derived scaffold repopulated with human amniotic fluid stem cells for potential application in myelomeningocele repair.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelomeningocele (MMC) is the most common congenital defect of the central nervous system, which results in devastating and lifelong disability. In MMC, the initial failure of neural tube closure early in gestation is followed by a progressive prenatal injury to the exposed spinal cord, contributing to the deterioration of neurological function in fetuses. Amniotic fluid, collected during intrauterine correction of MMC, has been investigated as a new cell source for stem cells in the development of future cell-based transplantation. Human amniotic fluid stem cells (hAFSCs) adhered on decellularized scaffolds can be an option for tissue regeneration and restoring spinal cord injury. This study evaluated a protocol for decellularizing human fetal skin (also collected during MMC corrective surgery) to create an extracellular matrix (dECM) scaffold and its subsequent recellularization with human amniotic fluid stem cells (hAFSCs). The successful adherence and viability of hAFSCs on the dECM scaffold demonstrated its potential as an in vitro tissue model for mechanical support and cell development. The findings of this study have significant implications for future MMC repair applications, as they describe viable morphological characteristics for using dECM scaffolds recellularized with hAFSCs as a potential therapy for MMC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.